- Report
- October 2023
- 85 Pages
United States
From €4542EUR$4,750USD£3,892GBP
- Report
- July 2023
- 89 Pages
Middle East
From €4207EUR$4,400USD£3,605GBP
- Report
- June 2020
- 464 Pages
Global
From €4686EUR$4,900USD£4,015GBP
- Report
- December 2019
- 381 Pages
Global
From €4302EUR$4,499USD£3,687GBP
- Report
- January 2022
- 234 Pages
Global
From €5020EUR$5,250USD£4,302GBP
- Report
- December 2022
- 425 Pages
Global
From €4771EUR$5,164USD£3,950GBP
- Report
- March 2021
Global
From €3227EUR$3,375USD£2,766GBP
€3586EUR$3,750USD£3,073GBP
- Report
- November 2018
- 281 Pages
Global
From €4733EUR$4,950USD£4,056GBP
- Report
- November 2020
- 133 Pages
Global
From €1315EUR$1,375USD£1,127GBP
€2630EUR$2,750USD£2,253GBP
- Report
- February 2018
- 192 Pages
Global
From €598EUR$625USD£512GBP
€1195EUR$1,250USD£1,024GBP
- Report
- December 2021
- 100 Pages
Global
From €5690EUR$5,950USD£4,875GBP
- Report
- September 2022
- 159 Pages
Middle East, Africa
From €2008EUR$2,100USD£1,721GBP
€2869EUR$3,000USD£2,458GBP
- Report
- September 2022
- 177 Pages
Europe
From €2008EUR$2,100USD£1,721GBP
€2869EUR$3,000USD£2,458GBP
- Report
- September 2022
- 177 Pages
Asia Pacific
From €2008EUR$2,100USD£1,721GBP
€2869EUR$3,000USD£2,458GBP
- Report
- September 2022
- 152 Pages
From €2008EUR$2,100USD£1,721GBP
€2869EUR$3,000USD£2,458GBP
- Report
- September 2022
- 157 Pages
North America
From €2008EUR$2,100USD£1,721GBP
€2869EUR$3,000USD£2,458GBP
- Report
- June 2022
- 240 Pages
Global
From €3046EUR$3,185USD£2,610GBP
€4351EUR$4,550USD£3,728GBP
- Report
- November 2019
- 141 Pages
From €2008EUR$2,100USD£1,721GBP
€2869EUR$3,000USD£2,458GBP
- Report
- August 2023
- 80 Pages
United Kingdom
From €2481EUR$2,595USD£2,126GBP
From €2481EUR$2,595USD£2,126GBP
The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods.
The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market.
Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more